Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression

Modern Pathology

Volumn 12, Issue 11, 1999, Pages 1025-1033

  Wong, Sandra Y Y ^a   Ngan, Hextan Y S ^a   Chan, Carina C W ^a   Cheung, Annie N Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Bar; Bcl 2; Gestational trophoblastic disease

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; TUMOR MARKER;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTROPHOBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STROMA CELL; SYNCYTIOTROPHOBLAST; TROPHOBLASTIC DISEASE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CHORIOCARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HUMANS; HYDATIDIFORM MOLE; IN SITU NICK-END LABELING; PREGNANCY; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR, PLACENTAL SITE; UTERINE NEOPLASMS;

EID: 0032708058     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 1992;11:95-103.
2. Cotter TG, Lennon SV, Glynn JG, Martin SJ. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumor and normal cells. Anticancer Res 1990;10:1153-9.
3. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
4. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
5. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14; 18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 229:1390-3.
6. Miyashita T, Reed JC. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 1992;52:5407-11.
7. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 1993;361:739-42.
8. Talley AK, Dewhurst S, Perry SW, Dollard SC, Gummuluru S, Fine SM, et al. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol Cell Biol 1995;15:2359-66.
9. Lotem J, Sachs L. Regulation of bcl-2, bcl-XE and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ 1995;6:647-53.
10. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN. Bcl-2/ Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993;4:327-32.
11. Vassilakos P, Riotton G, Kajii T. Hydatidiform mole: two entities. A morphologic and cytogenetic study with some clinical consideration. Am J Obstet Gynecol 1977;127:167-70.
12. Szulman AE, Surti U. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 1978;131:665-71.
13. Mazur MT, Kurman RJ. Gestational trophoblastic disease. In: Kurman RJ, editor. Blaustein's pathology of female genital tract. New York: Springer-Verlag; 1994. p. 1049-93.
14. Ma HK, Wong LC. Gestational trophoblastic disease in Hong Kong. Semin Oncol 1982;9:224-33.
15. Ma HK, Wong LC, Ngan HY. The modern management of trophoblastic disease. In: Bonnar J, editor. Recent advances in obstetrics and gynecology. Edinburgh: Churchill Livingstone; 1990. p. 3-23.
16. Elston CW, Bagshawe KD. The value of histological grading in the management of hydatidiform mole. J Obstet Gynaecol Br Commonw 1972;79:717-24.
17. Genest DR, Laborde O, Berkowitz RS, Goldstein DP, Bernstein MR, Lage J. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance. Obstet Gynecol 1991;78:402-9.
18. Cheung ANY, Sit ASY, Chung LP, Ngan HYS, O'Hanlan K, Wong LC, et al. Detection of heterozygous XY complete hydatidiform mole by chromosome in situ hybridization. Gynecol Oncol 1994;55:386-92.
19. van de Kaa CA, Schijf CP, de Wilde PC, de Leeuw H, Gemmink JH, Robben JC, et al. Persistent gestational trophoblastic disease: DNA image cytometry and interphase cytogenetics have limited predictive value. Mod Pathol 1996;9:1007-14.
20. Cheung AN, Ngan HY, Chen WZ, Loke SL, Collins RJ. The significance of proliferating cell nuclear antigen in human trophoblastic disease: an immunohistochemical study. Histopathology 1993;22:565-8.
21. Cheung AN, Ngan HY, Collins RJ, Wong YL. Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen. J Clin Pathol 1994;47:601-4.
22. Jeffers MD, Richmond JA, Smith R. Trophoblast proliferation rate does not predict progression to persistent gestational trophoblastic disease in complete hydatidiform mole. Int J Gynecol Pathol 1996;15:34-8.
23. Sugamura K, Makino M, Kaibara N. Apoptosis as a prognostic factor in colorectal carcinoma. Surg Today 1998;28:145-50.
24. Hellquist HB, Sundelin K, Di-Bacco A, Tytor M, Manzotti M, Viale G. Tumor growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labeling (TUNEL). J Pathol 1997;181:323-9.
25. Kayashima K, Ono T, Johno M, Kojo Y, Yamashita N, Matsunaga W. Spontaneous regression in Merkel cell (neuroendocrine) carcinoma of the skin. Arch Dermatol 1991;127: 550-3.
26. Fukasawa Y, Ishikura H, Takada A, Yokoyama S, Imamura M, Yoshiki T, et al. Massive apoptosis in infantile myofibromatosis. A putative mechanism of tumor regression. Am J Pathol 1994;144:480-5.
27. Hoehner JC, Hedborg F, Wiklund HJ, Olsen L, Pahlman S. Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression. Int J Cancer 1995;62:19-24.
28. Elston CW. Gestational trophoblastic disease. In: Fox H, editor. Haines and Taylor: obstetrical and gynaecological pathology. Edinburgh: Churchill Livingstone; 1995. p. 1597-640.
29. Yasuda M, Umemura S, Osamura RY, Kenjo T, Tsutsumi Y. Apoptotic cells in the human endometrium and placental villi: pitfalls in applying the TUNEL method. Arch Histol Cytol 1995;58:185-90.
30. Qiao S, Nagasaka T, Harada T, Nakashima N. p53, Bax, and Bcl-2 expression, apoptosis in gestational trophoblast of complete hydatidiform mole. Placenta 1998;19:361-9.
31. Kokawa K, Shikone T, Nakano R. Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester. Placenta 1998;19:21-6.
32. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994;71:219-25.
33. Lauritsen JG, Grunnet N, Jensen OM. Materno-fetal ABO incompatibility as a cause of spontaneous abortion. Clin Genet 1975;7:308-16.
34. Griffiths PD. The presumptive diagnosis of primary cytomegalovirus infection in early pregnancy by means of a radioimmunoassay for specific-IgM antibodies. Br J Obstet Gynaecol 1981;88:582-7.
35. Sen S, D'Incalci M. Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett 1992;307:122-7.
36. Wang TH, Wang HS. Gestational trophoblastic diseases: current trends and perspectives. J Formos Med Assoc 1995;94: 449-57.
37. Bursch W, Lauer B, Timmermann T, I, Barthel G, Schuppler J, Schulte HR. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 1984;5:453-8.
38. Oue T, Fukuzawa M, Kusafuka T, Kohmoto Y, Imura K, Nagahara S, et al. In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: relation to apoptosis and spontaneous regression. J Pediatr Surg 1996; 31:251-57.
39. Inada T, Kikuyama S, Ichikawa A, Igarashi S, Ogata Y. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma. Anticancer Res 1998;18:2003-10.
40. Zhang GJ, Kimijima I, Abe R, Watanabe T, Kanno M, Hara K, et al. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Anticancer Res 1998;18:1989-98.
41. Yamasaki F, Tokunaga O, Sugimori H. Apoptotic index in ovarian carcinoma: correction with clinicopathologic factors and prognosis. Gynecol Oncol 1997;66:439-48.
42. Soini Y, Tormanen U, Paakko P. Apoptosis is inversely related to bcl-2 but not to bax expression in salivary gland tumors. Histopathology 1998;32:28-34.
43. Steck K, McDonnell T, Sneige N, el-Naggar A. Flow cytometric analysis of apoptosis and bcl-2 in primary breast carcinomas: clinical and biological implications. Cytometry 1996; 24:116-22.
44. Park JR, Hockenbery DM. BCL-2, a novel regulator of apoptosis. J Cell Biochem 1996;60:12-7.
45. Messerli ML, Parmley T, Woodruff JD, Lilienfeld AM, Bevilacqua L, Rosenshein NB. Inter- and intra-pathologist variability in the diagnosis of gestational trophoblastic neoplasia. Obstet Gynecol 1987;69:622-6.
46. Lage JM. Diagnostic dilemmas in gynecologic and obstetric pathology. Semin Diagn Pathol 1990;7:146-55.
47. Howat AJ, Beck S, Fox H, Harris SC, Hill AS, Nicholson CM, et al. Can histopathologists reliably diagnose molar pregnancy? J Clin Pathol 1993;46:599-602.